Patients with multiple sclerosis (MS) show a high prevalence of myelin-reactive CD8+ and CD4+ T-cell responses, which are the putative effectors/modulators of CNS neuropathology. Utilizing a novel combination of short-term culture, CFSE-based sorting and anchored PCR, we evaluated clonal compositions of neuroantigen-targeting T-cells from RRMS patients and controls. CDR3 region analysis of TCRβ chains revealed biased use of specific TCRBV-bearing CD4+ clones. CD8+ clones showed homology to published TCR from CNS-infiltrating T-cells in MS lesions. These studies are the first description of TCR usage of CNS-specific CD8+ T-cells and provide insights into their potential regulatory role in disease.
Introduction
Multiple sclerosis (MS) is an inflammatory, demyelinating disorder of the central nervous system (CNS) that affects more than one million people worldwide. Although the etiology of MS is poorly understood, there is considerable evidence for an immune-mediated pathology, such as the presence of T-cell responses to myelin antigens (Martin et al., 1992) , a strong genetic association with certain HLA Class II haplotypes, and polymorphisms in cytokine receptors (Barcellos et al., 2006; Gregory et al., 2007; Hafler et al., 2007) . Evidence supporting the involvement of T-cells is based upon a vast body of work in an animal model of MS, experimental autoimmune encephalomyelitis (EAE). This well-characterized model can be induced by immunization with myelin sheath proteins such as myelin basic protein (MBP) (Einstein et al., 1962) , myelin oligodendrocyte glycoprotein (MOG) (Lebar et al., 1986) , or proteolipid protein (PLP) (Tuohy et al., 1988; Wekerle, 1991) or by adoptive transfer of neuroantigen-targeting T-cells which can commute disease to a new host (Pettinelli and McFarlin, 1981) .
Specifically, autoreactive CD4+ Th 1 /Th 17 T-cells are believed to be the principle mediators of both EAE and MS, based on several observations, such as: IL-2 and IFN-γ production by infiltrating CD4+ T-cells isolated from the CNS of mice with acute EAE (Renno et al., 1995) , presence of Th 1 -inducing cytokines in inflammatory lesions and treatment of mice with Th 1 -inducing cytokines resulting in aggravation of autoimmune disease (Gutcher and Becher, 2007) and analysis of gene transcripts in chronic MS lesions revealing an increased level of IL-17 transcripts when compared to acute lesions or control tissues from healthy subjects (Lock et al., 2002) . Additionally, CD8+ T-cells are also believed to play a role in this autoimmune disease as revealed by MS and EAE studies. For example, CD8+ and CD4+ T-cells were found in demyelinating MS lesions (Traugott et al., 1983) , CD8+ T-cells predominating and exhibiting oligoclonal expansion within the lesions (Babbe et al., 2000; Monteiro et al., 1996) . We have previously shown that CD4+ and CD8+ T-cell responses to neuroantigens could be detected in MS as well as healthy individuals, with slightly higher CD8+ T-cell responses to myelinassociated oligodendrocytic basic protein (MOBP) in RRMS (Crawford et al., 2004) . Studies using transgenic and wildtype myelin-specific CD8+ T-cells have revealed a potential pathogenic or regulatory role in certain models of EAE (Huseby et al., 2001; Steinman, 2001; Sun et al., 2001; York et al., 2010) . Our recent studies, both in EAE (York Journal of Neuroimmunology 234 (2011) 131-140 
